Ceftriaxone
Ceftriaxone is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Lower respiratory tract infections
- Acute bacterial otitis media
- Skin and skin-structure infections
- Urinary tract infections (complicated and uncomplicated)
- Uncomplicated gonorrhea
- Pelvic inflammatory disease
- Septicemia
- Bone and joint infections
- Intra-abdominal infections
- Meningitis and surgical prophylaxis
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Brain abscess (with metronidazole)
- Appendicitis (with metronidazole)
- Peritonitis: spontaneous bacterial and secondary
- Endocarditis
- Diabetic foot infections (with metronidazole or clindamycin)
- Lyme disease: late Lyme arthritis and neuroborreliosis
- Meningococcal meningitis prophylaxis: 125 mg x1 (< 15 yrs); 250 mg x1 (≥15 yrs)
- Neurosyphilis
- Disseminated GC
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
- Lower respiratory tract infections
- Acute bacterial otitis media
- Skin and skin-structure infections
- Urinary tract infections (complicated and uncomplicated)
- Uncomplicated gonorrhea
- Pelvic inflammatory disease
- Septicemia
- Bone and joint infections
- Intra-abdominal infections
- Meningitis and surgical prophylaxis
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Brain abscess (with metronidazole)
- Appendicitis (with metronidazole)
- Peritonitis: spontaneous bacterial and secondary
- Endocarditis
- Diabetic foot infections (with metronidazole or clindamycin)
- Lyme disease: late Lyme arthritis and neuroborreliosis
- Meningococcal meningitis prophylaxis: 125 mg x1 (< 15 yrs); 250 mg x1 (≥15 yrs)
- Neurosyphilis
- Disseminated GC
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: September 29, 2018
Citation
Dzintars, Kathryn, and Paul A Pham. "Ceftriaxone." Johns Hopkins ABX Guide, The Johns Hopkins University, 2018. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540104/4.2/Ceftriaxone.
Dzintars K, Pham PA. Ceftriaxone. Johns Hopkins ABX Guide. The Johns Hopkins University; 2018. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540104/4.2/Ceftriaxone. Accessed March 30, 2023.
Dzintars, K., & Pham, P. A. (2018). Ceftriaxone. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540104/4.2/Ceftriaxone
Dzintars K, Pham PA. Ceftriaxone [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2018. [cited 2023 March 30]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540104/4.2/Ceftriaxone.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ceftriaxone
ID - 540104
A1 - Dzintars,Kathryn,Pharm.D., BCPS
AU - Pham,Paul,Pharm.D.
Y1 - 2018/09/29/
BT - Johns Hopkins ABX Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540104/4.2/Ceftriaxone
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -